Statistics
Publications
14
Citations
1.7K
H-Index
14
Active since
2007
Jacob R. Haling is an author at Genomics Institute of the Novartis Research Foundation specializing in medicine, molecular oncology, and oncology.
Publications per year
2007–2024
14
14
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
Jill Hallin, Vickie Bowcut, Andrew Calinisan et al. · Nature Medicine · 2022 · 507 citations
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
Georgia Hatzivassiliou, Jacob R. Haling, Huifen Chen et al. · Nature · 2013 · 320 citations
Medicine, Cancer Biology, Oncology +14
John M. Ketcham, Jacob R. Haling, Shilpi Khare et al. · Journal of Medicinal Chemistry · 2022 · 94 citations · Full text
1–5 of 14